title: [Immunosuppressive therapy following penetrating keratoplasty (author's transl)].
abstract: In 6 cases with poor prognosis who had undergone perforating keratoplasty, the local steroid therapy was combined, for an average duration of 15 months, with a systemic treatment of cyclophosphamide and procarbazine. During a postoperative following up duration between 19 and 32 months five grafts remained clear, however, in 1 case this therapy could not stop an allograft reaction.
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D016039:Corneal Transplantation; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D007165:Immunosuppression Therapy; D008875:Middle Aged; D011344:Procarbazine / Q000627:therapeutic use*; D014184:Transplantation, Homologous
chemical_list: D000305:Adrenal Cortex Hormones; D011344:Procarbazine; D003520:Cyclophosphamide
vernacular_title: Immunosuppressive Therapie nach perforierender Keratoplastik.